PRKN and glioblastoma: According to the above results, we speculate that the tumor-promoting potential of HSD11B1L-181 may be achieved partly by binding and inhibiting the activity of parkin, and finally enhancing the characteristics of proliferation, migration and invasion of GBM cells.